Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07877103
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07877103
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07877103. Randomized; no masking; primary purpose treatment. Start 2026-10-25 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
- Condition
- End-Stage Renal Disease
- Intervention (Drug)
- Chronotherapy-based individualized low-morning high-evening tacrolimus dosing
- Intervention (Drug)
- conventional dosing regimen
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Collaborator
- Second Affiliated Hospital of Guangzhou Medical University
- Collaborator
- The Third Affiliated Hospital of Guangzhou Medical University
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Collaborator
- Zhujiang Hospital
Record details
- Record id
cardio:ct-nct07877103- Content hash
8abc1bc17f48ef427794cb0bf25452b6d3d781c0815362855d54c10f0f59c4f4